R&D Views & Analysis | pharmaphorum

Views & Analysis

R&D

Pre-emptive medicine: Pushing the boundaries of preventative...

The upcoming World Without Disease summit, scheduled for 21st June in London, aims to explore innovative ways to facilitate earlier disease prediction, prevention, and interception.

R&D

Headlines and hot topics from ASCO and BIO, with Jonah Comst...

This week, pharmaphorum editor-in-chief Jonah Comstock headed to not one, but two back-to-back events in the US.

R&D

One size does not fit all: Why a shift is needed in how we t...

Two of the biggest advances in healthcare in the last decade have been the gradual de-stigmatisation of mental health and the increased interest in researching the causes and treatments of

R&D

Stephen Head, senior director, Patient Partnerships at Astellas Pharma Europe

How can we achieve a world without disease?

Delivering the vision of a world where disease is no longer an insurmountable burden for patients and healthcare professionals would be a phenomenal achievement in the history of medicine.

Oncology

Why are rates of HPV vaccination declining globally?

Despite the world possessing effective vaccines against HPV, rates of immunisation are actually falling in lower- and middle-income countries.

R&D

3 ways artificial intelligence can improve the clinical tria...

As artificial intelligence (AI) continues to make significant advances, the leaders of clinical trials should not underestimate its capabilities for improving patient recruitment, retention